Ridaura
(Auranofin)Phase 2Small molecule
This medication is used to treat rheumatoid arthritis by reducing symptoms like joint pain, swelling, and morning stiffness. It works best when combined with rest and other non-drug treatments, though it typically takes 3-6 months to feel its full effect.[1] Ridaura is currently being investigated across 1 indication[3], with its most advanced program in Phase 2.[1]
Ridaura is one of 27 small molecule programs targeting HIV. It is currently in Phase 2.
1
Indications
13
Total Trials
1
Active Trials
26
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
44 competitors in HIV
#DrugCompanyPhaseTrials
1Tivicay
GSKApproved
Cabenuva
GSKApproved
Sustiva
KKaruna Therapeutics, Inc., a Bristol Myers Squibb company
Approved
Pifeltro
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Approved
Epivir
GGlaxo Dba Glaxosmithkline
Phase 3
Fostemsavir
GSKPhase 3
INCMGA00012
IncytePhase 3
Selzentry
GSKPhase 2
Daraprim
FFondazione Matilde Tettamanti Menotti De Marchi Onlus
Phase 2
Fosamax
OOrganon and Co
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Non-Small Cell Lung Cancer2 trials
Fallopian Tube Cancer1 trial
Oral1 trial
Auranofin PK Following Oral Dose Administration
Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT02089048·15 enrolled
Glioblastoma1 trial
7 more indications
HIV-11 trial
HIV infection1 trial
TED1 trial
HIV1 trial
Unspecified1 trial
Auranofin for Giardia Protozoa
Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT02736968·93 enrolled
Regulatory
FDA Approval Timeline[4]
May 24, 1985
RIDAURA
NDA NDA018689
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Auranofin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
- [5]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- LLegacy Health System